Skip to main navigation Skip to search Skip to main content

Vanillin and vanillin analogs relax porcine coronary and basilar arteries by inhibiting L-type Ca2+ channels

  • Gábor Raffai*
  • , Gilson Khang
  • , Paul M. Vanhoutte
  • *Corresponding author for this work
  • Jeonbuk National University
  • The University of Hong Kong

Research output: Contribution to journalJournal articlepeer-review

Abstract

Vanillin (VA) and vanillyl alcohol (VAA), components of natural vanilla, and ethyl vanillin (EtVA; synthetic analog) are used as flavoring agents and/or as additives by the food, cosmetic, or pharmaceutic industries. VA, VAA, and EtVA possess antioxidant and anti-inflammatory properties, but their vascular effects have not been determined. Therefore, we compared in isolated porcine coronary and basilar arteries the changes in isometric tension caused by VA, VAA, and EtVA. VA and its analogs caused concentration-dependent relaxations of both preparations during contractions from U46619 (9,11-dideoxy-11a,9α-epoxymethanoprostaglandin F2α, a thromboxane A2 receptor agonist), and of coronary arteries contracted with KCl or endothelin-1. The order of potency was VAA < VA < EtVA. The relaxations were not inhibited by endothelium removal, by inhibitors of NO synthases (Nω- nitro-L-arginine methyl ester hydrochloride), cyclooxygenases (indomethacin), soluble guanylyl cyclase (1H -[1,2,4]oxadiazolo[4,3- a ]quinoxalin-1-one [ODQ]), KCa (1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole [TRAM-34], 6,12,19,20,25,26-hexahydro-5,27:13,18:21,24-trietheno-11,7-metheno-7H-dibenzo[b,n][1,5,12,16]tetraazacyclotricosine-5,13-diium ditrifluoroacetate hydrate [UCL-1684], or iberiotoxin), by KATP (glibenclamide), by Kir (BaCl2), by transient receptor potential receptor vanilloid 3 (TRPV3) channels (ruthenium red), or by antioxidants (catalase, apocynin, tempol, N-acetylcysteine, tiron). VA and its analogs inhibited contractions induced by Ca2+ reintroduction in coronary arteries, and by an opener of L-type Ca2+-channels (methyl 2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl) phenyl]-1,4-dihydropyridine-3-carboxylate [Bay K8644]) in coronary and basilar arteries. They inhibited contractions of coronary rings induced by the protein kinase C activator phorbol 12,13-dibutyrate to the same extent as the removal of extracellular Ca2+ or incubation with nifedipine. Thus, in porcine arteries, relaxation from VA (and its analogs) is due to inhibition of L-type Ca2+ channels. Hence, these compounds could be used to relieve coronary or cerebral vasospasms due to exaggerated Ca2+ influx, but therapeutic efficacy would require exposures that far exceed the current levels obtained by the use of vanillin additives.

Original languageEnglish
Article numberA7
Pages (from-to)14-22
Number of pages9
JournalJournal of Pharmacology and Experimental Therapeutics
Volume352
Issue number1
DOIs
StatePublished - 2015.01.1

Quacquarelli Symonds(QS) Subject Topics

  • Medicine
  • Pharmacy & Pharmacology

Fingerprint

Dive into the research topics of 'Vanillin and vanillin analogs relax porcine coronary and basilar arteries by inhibiting L-type Ca2+ channels'. Together they form a unique fingerprint.

Cite this